Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer

Cancer Research

Volumn 60, Issue 17, 2000, Pages 4667-4677

  Williams, J A ^a   Phillips, D H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450; EPOXIDE HYDROLASE; ESTROGEN; GLUTATHIONE TRANSFERASE; HETEROCYCLIC AMINE; PEROXIDASE; POLYCYCLIC AROMATIC HYDROCARBON; SULFOTRANSFERASE; XENOBIOTIC AGENT;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONJUGATION; DNA ADDUCT; ENZYME ACTIVATION; GENETIC POLYMORPHISM; GENOTOXICITY; HUMAN; PENETRANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; XENOBIOTIC METABOLISM;

ANIMALS; BIOTRANSFORMATION; BREAST; BREAST NEOPLASMS; CARCINOGENS; FEMALE; HUMANS; METABOLIC DETOXICATION, DRUG; RISK FACTORS; XENOBIOTICS;

EID: 0034282750     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (187)

1. Epidemiology and prevention of breast cancer
2. Diet, nutrition, and avoidable cancer
3. Risk factors for breast cancer development
4. New role for estrogen in cancer?
5. The genetic basis of breast cancer and its clinical implications
6. Cellular basis of breast cancer susceptibility
7. The development of the normal human breast
8. Hormone-induced ductal DNA synthesis of human breast tissues maintained in the athymic nude mouse
9. Major differences in breast cancer risks among occupations
10. Environmental risk factors of breast cancer
11. Breast cancer and occupational exposures in women in Finland
12. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980
13. Genotoxicity of human mammary lipid
14. Adipose tissue, a neglected factor in aetiology of breast cancer?
15. Mutagenic activity in nipple aspirates of human breast fluid
16. The mutagenic activity of human breast secretions
17. Mutagens in human breast cyst fluid
18. DNA damage in breast epithelial cells: Detection by the single-cell gel (comet) assay and induction by human mammary lipid extracts
19. Genotoxicity of human milk extracts and detection of DNA damage in exfoliated cells recovered from breast milk
20. DNA damage in human breast milk cells and its induction by 'early' and 'late' milk extracts
21. Evidence for arylamines in human breast carcinogenesis
22. 32P-postlabeling analysis of DNA adducts in human and rat mammary epithelial cells
23. Carcinogen-DNA adducts in human breast tissue
24. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology
25. DNA adducts in human breast tissue: Association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes
26. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues
27. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk
28. 8-Hydroxydeoxyguanosine levels in DNA of human breast cancer are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method
29. Increased formation of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes
30. Environmental carcinogens that may be involved in human breast cancer etiology
31. The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: Functional and localization studies
32. Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods
33. Polycyclic aromatic hydrocarbons in the diet
34. The identification of polynuclear aromatic hydrocarbon (PAH) derivatives in mutagenic fractions of diesel particulate extracts
35. Aromatic amines and cancer
36. Assessing human risk to heterocyclic amines
37. Smoking as a risk factor for breast cancer
38. The estrogenicity of selected nutrients, phytochemicals, pesticides, and pollutants: Their potential roles in breast cancer
39. Organochlorine exposure and risk of breast cancer
40. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer
41. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
42. Cancer initiation by polycyctic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites
43. Lack of tumorigenicity of cholesterol epoxides and estrone-3,4-quinone in the rat mammary gland
44. Cholesterol and cholesterol epoxides in nipple aspirates of human breast fluid
45. Nurturing and breast-feeding: Exposure to chemicals in breast milk
46. Detection of monocyclic aromatic amines, possible mammary carcinogens, in human milk
47. Comparative carcinogenicity of o-toluidine hydrochloride and o-nitrosotoluene in F-344 rats
48. Polycyclic aromatic hydrocarbons in human fat and liver
49. The role of aromatic hydrocarbons in the genesis of breast cancer
50. Some perspectives on the nutritional aspects of breast cancer research. Food-derived heterocyclic amines as etiologic agents in human mammary cancer
51. Polycyclic hydrocarbon activation and metabolism in epithelial cell aggregates prepared from human mammary tissue
52. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: Role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism
53. Metabolic activation and DNA binding of food mutagens and other environmental carcinogens in human mammary epithelial cells
54. N-Acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland
55. Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells
56. Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline in the human breast
57. The identification of [2-(14)C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans
58. Alkylation of intracellular and extracellular DNA by dimethylnitrosamine following activation by isolated rat hepatocytes
59. Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7β,8α-dihydroxy-9α, 10α-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice
60. Metabolism of benzo(a)pyrene by isolated hepatocytes and factors affecting covalent binding of benzo(a)pyrene metabolites to DNA in hepatocyte and microsomal systems
61. Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and effect of dietary fat
62. Metabolic activation and DNA adduct detection of PhlP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis
63. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans
64. Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative
65. The metabolism of 2-amino-3,8-dimethylimdiazo[4,5-f]quinoxaline in human hepatocytes
66. Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammaplasties
67. Human mammary NAT and SULT enzymes metabolically activate N-hydroxylated heterocyclic amines, but NAT enzyme activity is not influenced by NAT genotype
68. Expression of cytochromes P450 in human breast tissue and tumors
69. Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells
70. Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: Role of the Ah receptor
71. Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts
72. Cytochrome P450 knockout mice: New toxicological models
73. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature
74. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis
75. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues
76. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue
77. Human cytochrome P4501A2
78. Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells
79. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1
80. P450 enzymes of estrogen metabolism
81. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1
82. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis
83. Up-regulation of cytochrome P450 1A2, 2C9, and 2E1 in chronic pancreatitis
84. Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue
85. The steroid hormone dehydroepiandrosterone inhibits CYP1A1 expression in vitro by a post-transcriptional mechanism
86. Hormonal carcinogenesis: Separation of estrogenicity from carcinogenicity
87. A systematic review of genetic polymorphisms and breast cancer risk
88. Functional significance of different human CYP1A1 genotypes
89. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene
90. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility
91. 462: Assessment of a role for the rare allele in carcinogenesis
92. Cytochrome P4501A1 and glutathione S-transferase (MI) genetic polymorphisms and postmenopausal breast cancer risk
93. Human CYP1A1 gene: Cosegregation of the enzyme inducibility phenotype and an RFLP
94. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans
95. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women
96. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study
97. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility
98. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer
99. Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17α-ethinyloestradiol. Relative activities of rat and human liver enzymes
100. Alternative splicing of CYP2D mRNA in human breast tissue
101. Species differences in metabolism and pharmacokinetics: Are we close to an understanding?
102. Benzene, an experimental multipotential carcinogen: Results of the long-term bioassays performed at the Bologna Institute of Oncology
103. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA
104. Ethanol consumption and DMBA-induced mammary carcinogenesis in rats
105. Enhancement by chronic ethanol intake of N-methyl-N-nitrosourea-induced rat mammary tumorigenesis
106. Nutrition and cancer
107. Structure-function relationships of human liver cytochromes P450 3A: Aflatoxin B1 metabolism as a probe
108. Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues
109. Aromatase expression in the human breast
110. A rare CYP19 (aromatase) variant may increase the risk of breast cancer
111. ASO Distinguished Achievement Award Lecture. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid
112. Aromatase inhibitors as potential cancer chemopreventives
113. Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors
114. Soluble and membrane-bound catechol-O-methyltransferase in normal and malignant mammary gland
115. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders
116. Catechol-O-methyltransferase and breast cancer risk
117. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk
118. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer
119. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer
120. Human microsomal epoxide hydrolase: 5'-flanking region genetic polymorphisms
121. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: Influence on cancer susceptibility
122. Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours
123. Human acetyltransferase polymorphisms
124. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe
125. Genotyping human arylamine N-acetyltransferase type 1 (NAT1): The identification of two novel allelic variants
126. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue
127. Placental expression of arylamine N-acetyltransferases: Evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2
128. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk
129. N-Acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk
130. NAT2*12A (803A→G) codes for rapid arylamine N-acetylation in humans
131. Histological localisation of acetyltransferases in human tissue
132. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk
133. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer
134. Heterocyclic amines: Evaluation of their role in diet associated human cancer
135. Well-done meat intake and the risk of breast cancer
136. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms
137. N-Acetyl transferase 2 genotypes, meat intake and breast cancer risk
138. Metabolic activation of methyl-hydroxylated derivatives of 7,12- dimethylbenz[a]anthracene by human liver dehydroepiandrosterone-steroid sulfotransferase
139. Bioactivation of the proximal food mutagen 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) to DNA-binding species by human mammary gland enzymes
140. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines
141. Sulfotransferase catalyzing sulfation of heterocyclic amines
142. Human phenol sulfotransferases SULT1A2 and SULT1A1: Genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations
143. Additional polymorphisms and cancer
144. Functional role of estrogen metabolism in target cells: Review and perspectives
145. Characterization and regulation of UDP-glucumnosyltransferases in steroid target tissues
146. Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry
147. Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucaronides
148. Potential use of D-glucaric acid derivatives in cancer prevention
149. Three MspI polymorphisms at the UGT1 locus
150. Molecular genetic basis of Gilbert's syndrome
151. Human glutathione S-transferases
152. Enzymic and interindividual differences in the human metabolism of heterocyclic amines
153. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer
154. Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility
155. Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants
156. The role of peroxidase-catalyzed activation of aromatic amines in breast cancer
157. The 1996 Veylien Henderson Award of the Society of Toxicology of Canada. Current concepts: Neutrophils and the activation of carcinogens in the breast and other organs
158. Molecular cloning of cDNAs encoding bovine and human lactoperoxidase
159. Mammalian endogenous peroxidases as cellular markers and as biosynthetic endpoints of hormone-mediated activity: Viewpoint from cytochemistry
160. Primary aromatic amines: Their N-oxidative bioactivation
161. The metabolism of 17β-estradiol by lactoperoxidase: A possible source of oxidative stress in breast cancer
162. Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine
163. Oxidative DNA damage induced by activation of polychlorinated biphenyls (PCBs): Implications for PCB-induced oxidative stress in breast cancer
164. Activation of the food derived carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat pleural cavity inflammatory cells
165. Nucleic acid binding of arylamines during the respiratory burst of human granulocytes
166. Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes: Possible link between inflammation and cancer
167. Myeloperoxidase genetic polymorphism and lung cancer risk
168. Breast fluid cholesterol and cholesterol epoxides: Relationship to breast cancer risk factors and other characteristics
169. Hepatocarcinogens induce gene mutations in rats in fibroblast-like cells from a subcutaneous granulation tissue
170. Prostaglandin-H synthase mediated metabolism and mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline (1Q)
171. Metabolism of benzo(a)pyrene to reactive intermediate(s) via prostaglandin biosynthesis
172. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
173. Lipoxygenase inhibitors as potential cancer chemopreventives
174. Rat pulmonary lipoxygenase: Dioxygenase activity and role in xenobiotic metabolism
175. Arachidonic acid-dependent activation of benzo-[a]pyrene to bind to proteins with cytosolic and microsomal fractions from rat liver and lung
176. Increased 12-lipoxygenase expression in breast cancer tissues and cells. Regulation by epidermal growth factor
177. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer
178. Genetic polymorphisms and risk of breast cancer
179. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes
180. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes
181. Purification of human liver microsomal epoxide hydrase. Differences in the properties of the human and rat enzymes
182. Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring
183. Aflatoxin B1 epoxidation catalysed by partially purified human liver lipoxygenase
184. Co-oxidative metabolism of 4-aminobiphenyl by lipoxygenase from soybean and human term placenta